30 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Moneygram International Inc MGI rose 128.3% to $3.31 in pre-market trading after the company reported a strategic partnership with Ripple. Blockchain payments firm Ripple has made an investment in MoneyGram and will also allow the group to use its XRP cryptocurrency as part of the cross-border payments process. Ripple made an initial investment of $30 million in the money transfer company, made up of common stock and a warrant to purchase common stock. Ripple purchased newly-issued common stock including the shares underlying the warrant from MoneyGram at $4.10 per share.
• Blue Apron Holdings, Inc. APRN rose 27.8% to $10.45 in pre-market trading.
• Beyond Meat, Inc. BYND rose 16% to $197.00 in pre-market trading after surging 12.20% on Monday.
• PhaseBio Pharmaceuticals, Inc. PHAS rose 12.5% to $13.80 in pre-market trading after the company reported positive preliminary results from Phase 2a clinical trial of PB2452.
• Eiger Biopharmaceuticals Inc EIGR rose 9.6% to $11.50 in pre-market trading after the company announced a breakthrough therapy designation granted by the FDA for avexitide for treatment of post-bariatric hypoglycemia.
• Cemtrex, Inc. CETX rose 9.3% to $3.18 in pre-market trading after gaining 8.18% on Monday.
• SunPower Corporation SPWR rose 8.7% to $9.00 in pre-market trading. Goldman Sachs upgraded SunPower from Neutral to Buy and announced a $11 price target.
• ACM Research, Inc. ACMR rose 7.6% to $18.00 in pre-market trading after highlighting strategic plan to extend access to China's capital markets.
• Galectin Therapeutics, Inc. GALT rose 7% to $4.00 in pre-market trading.
• Sunrun Inc. RUN rose 6.2% to $18.15 in pre-market trading. Goldman Sachs upgraded Sunrun from Neutral to Buy and announced a $20 price target.
• ArQule, Inc. ARQL rose 6.1% to $10.16 in pre-market trading after gaining 16.83% on Monday.
• Celldex Therapeutics, Inc. CLDX gained 5.7% to $2.80 in pre-market trading after climbing 6.85% on Monday.
• Parsons Corporation PSN shares rose 5.3% to $33.00 in pre-market trading after reporting strong Q1 sales.
• Precipio, Inc. PRPO rose 5% to $3.38 in pre-market trading after falling 21.08% on Monday.
• Switch, Inc. SWCH rose 4.6% to $13.80 in pre-market trading.
• Riot Blockchain, Inc. RIOT shares rose 4.3% to $2.93 in pre-market trading.
Holly Energy Partners, L.P. HEP rose 4.2% to $28.42 in pre-market trading.
• Lannett Company, Inc. LCI rose 3.8% to $5.50 in pre-market trading after the company reported a restructuring plan related to Cody Labs. The company says it sees incurring around $5 million in costs to implement Cody API Restructuring Plan.
• Snap Inc SNAP rose 3.5% to $14.02 in pre-market trading after BTIG raised price target on stock from $15 to $20.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Biohaven Pharmaceutical Holding Company Ltd. BHVN fell 27.6% to $41.50 in pre-market trading after the company reported proposed public $300 million offering of common shares.
• Rockwell Medical, Inc. RMTI shares fell 27.4% to $3.20 in pre-market trading after the company reported a common stock offering with no disclosed size.
• Calithera Biosciences, Inc. CALA fell 12.1% to $5.10 in pre-market trading after the company reported a common stock offering of 10 million shares.
• ContraVir Pharmaceuticals, Inc. CTRV fell 10.6% to $8.68 in pre-market trading after rising 9.22% on Monday.
• Seelos Therapeutics, Inc. SEEL fell 8.7% to $2.00 in pre-market trading.
• Pacific Biosciences of California, Inc. PACB fell 7.2% to $6.20 in pre-market trading.
• PG&E Corporation PCG fell 4.7% to $18.00 in pre-market trading.
• Maxar Technologies Inc. MAXR fell 4.4% to $6.47 in pre-market trading.
• Hemispherx Biopharma, Inc. HEB fell 4.2% to $4.60 in pre-market trading after dropping 5.51% on Monday.
• Jumia Technologies AG JMIA fell 3.5% to $22.52 in pre-market trading after dropping 3.71% on Monday.
• Ebix, Inc. EBIX fell 3% to $45.32 in pre-market trading after dropping 12.56% on Monday.